Custom Antibody Global Market Report 2025

The custom antibody market size has grown rapidly in recent years. It will grow from $0.42 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth during the historic period can be attributed to the rising demand for custom antibodies, the expanding use of precision medicine, the increasing prevalence of chronic diseases and cancer, the surge in research and development activities, and the growing number of clinical trials.

The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to the increasing adoption of targeted immunotherapy, rising investment in biopharmaceuticals, the growing prevalence of neurodegenerative diseases, the expanding demand for in vitro diagnostics (IVD) applications, and rising healthcare expenditures. Key trends in the forecast period include the rise of personalized medicine, technological advancements in antibody engineering, progress in biotechnology and genetic engineering, expanding therapeutic applications, and innovations in antibody purification techniques.

The increasing demand for personalized medicine is anticipated to drive the expansion of the custom antibody market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies based on an individual's genetic makeup, lifestyle, and environmental factors. The rising demand for personalized medicine is fueled by advancements in genomics, the growing availability of biomarker-based therapies, and a heightened consumer preference for customized treatment options that enhance efficacy while minimizing adverse effects. Custom antibodies support personalized medicine by providing highly specific immune reagents that improve disease detection, therapeutic targeting, and biomarker identification for individualized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022. As a result, the increasing demand for personalized medicine is driving the growth of the custom antibody market.

Leading companies in the custom antibody market are increasingly integrating advanced technologies such as artificial intelligence to enhance antibody discovery, improve specificity, and accelerate development processes. Artificial intelligence aids custom antibody development by refining antigen selection, predicting antibody-antigen interactions, and streamlining candidate screening using machine learning, ultimately leading to faster and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, launched with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon's proprietary technology assembles antibodies into cage structures, allowing modifications to their properties without altering their core structures. This innovation is designed to enhance antibody affinity for therapeutic targets while reducing off-target interactions, improving both efficacy and safety.

In September 2024, Leinco Technologies Inc., a US-based biotechnology company, acquired QED Biosciences Inc. for an undisclosed amount. This acquisition is intended to support Leinco Technologies' strategic growth by expanding its market presence and strengthening its offerings in the life sciences and IVD raw material sectors. QED Bioscience Inc., also a US-based biotechnology company, specializes in the design and production of custom antibodies.

Major players in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS.

North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in custom antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the custom antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A custom antibody is a laboratory-engineered antibody specifically developed to target a particular antigen of interest. These antibodies are designed for research, diagnostic, or therapeutic purposes, catering to the unique requirements of scientists and healthcare professionals. Custom antibodies play a crucial role in biomedical research, diagnostics, and drug development, enabling precise detection and targeting of biomolecules.

The primary types of custom antibodies include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other variants. Monoclonal antibodies are lab-created molecules that precisely target a specific antigen, mimicking the immune system's natural pathogen-fighting mechanism. Services in this market encompass antibody development, production and purification, as well as fragmentation and labeling. The sources of custom antibodies include mice, rabbits, and other organisms. These antibodies are utilized in various fields such as oncology, infectious diseases, neurology, stem cell research, immunology, and cardiovascular diseases. The key end users of custom antibodies include pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and hospitals and clinics.

The custom antibody market research report is one of a series of new reports that provides custom antibody market statistics, including the custom antibody industry global market size, regional shares, competitors with the custom antibody market share, detailed custom antibody market segments, market trends, and opportunities, and any further data you may need to thrive in the custom antibody industry. This custom antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The custom antibody market consists of revenues earned by entities by providing services such as antibody production, antibody purification, and conjugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The custom antibody market also consists of sales of products including antibody fragments, conjugated antibodies, and secondary antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.